Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Increasing life expectancy has led to an aging population, which has consequently increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of dementia worldwide, is estimated to make up 50–80% of all cases. AD cases are expected to reach 131 million by 2050, and this...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Nanobiotechnology
Huvudupphovsmän: Cano, Amanda, Turowski, Patric, Ettcheto, Miren, Duskey, Jason Thomas, Tosi, Giovanni, Sánchez-López, Elena, García, Maria Luisa, Camins, Antonio, Souto, Eliana B., Ruiz, Agustín, Marquié, Marta, Boada, Mercè
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8086346/
https://ncbi.nlm.nih.gov/pubmed/33926475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00864-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk